Literature DB >> 22797455

The acute respiratory distress syndrome: what's in a name?

Derek C Angus.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22797455     DOI： 10.1001/jama.2012.6761

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Defining ARDS: do we need a mandatory waiting period?

Authors:  V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson
Journal:  Intensive Care Med       Date:  2013-01-31       Impact factor: 17.440

2.  A detailed evaluation of the new acute kidney injury criteria by KDIGO in critically ill patients.

Authors:  Junichi Izawa; Shigehiko Uchino; Masanori Takinami
Journal:  J Anesth       Date:  2015-12-08       Impact factor: 2.078

3.  Surfactant protein-A nanobody-conjugated liposomes loaded with methylprednisolone increase lung-targeting specificity and therapeutic effect for acute lung injury.

Authors:  Nan Li; Dong Weng; Shan-Mei Wang; Yuan Zhang; Shan-Shan Chen; Zhao-Fang Yin; Jiali Zhai; Judy Scoble; Charlotte C Williams; Tao Chen; Hui Qiu; Qin Wu; Meng-Meng Zhao; Li-Qin Lu; Xavier Mulet; Hui-Ping Li
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

4.  Risk factors for transient dysfunction of gas exchange after cardiac surgery.

Authors:  Cristiane Delgado Alves Rodrigues; Marcos Mello Moreira; Núbia Maria Freire Vieira Lima; Luciana Castilho de Figueirêdo; Antônio Luis Eiras Falcão; Orlando Petrucci Junior; Desanka Dragosavac
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Jan-Mar

5.  Extravascular lung water and the pulmonary vascular permeability index may improve the definition of ARDS.

Authors:  Azriel Perel
Journal:  Crit Care       Date:  2013-01-24       Impact factor: 9.097

Review 6.  Surfactants in Acute Respiratory Distress Syndrome in Infants and Children: Past, Present and Future.

Authors:  Angela Amigoni; Andrea Pettenazzo; Valentina Stritoni; Maria Circelli
Journal:  Clin Drug Investig       Date:  2017-08       Impact factor: 2.859
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.